126th Meeting of the National Advisory Council on Drug Abuse
Neuroscience Center - Conference Rooms C & D
6001 Executive Boulevard, Bethesda, MD.
May 2, 2017
Closed Session
This meeting is closed to the public in accordance with the provisions set forth in section 552b{c} and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).
| 9:00 a.m. |
Call to Order Review of Policy and Procedures |
| 9:15 a.m. |
Council Review of Grant Applications Division of Therapeutics and Medical Consequences (DTMC) Division of Neuroscience and Behavior (DNB) Division of Epidemiology, Services, and Prevention Research (DESPR) Update on Tobacco Industry Funding Issue |
| 10:30 a.m. | Break |
WebEx Information (Open Session Only)
Topic: WebEx - 126th Meeting, National Advisory Council on Drug Abuse
Date and Time: Tuesday, May 2, 2017 - 10:30 a.m. Eastern Daylight Time, 7 hours
Meeting Number (Access Code):
291 034 912
Password: Success1
To start the online event
At least 30 minutes before the starting time:
- Start your meeting.
- If requested, enter in your name and email address.
- If a password is required, enter in the meeting password: Success1
- Click “Join”.
Join by phone
Call-in toll-free number (US/Canada) – 1-877-668-4493
Call-in toll number (US/Canada) – 1-650-479-3208
Meeting Access Code – 291 034 912
Open Session
| 10:45 a.m. | Welcome and Opening Remarks Nora Volkow, M.D. Director, NIDA |
| 11:00 a.m. | Director's Report Nora Volkow, M.D. Director, NIDA |
| 12:00 p.m. | Council Discussion Council Members |
| 12:30 p.m. | Lunch Break (Steering Group Meeting) |
| 1:45 p.m. |
Briefing on NASEM Marijuana Report: Background, Methods & Therapeutic Benefits Adverse Effects & Recommendations |
| 2:45 p.m. |
Break |
| 3:00 p.m. |
The Biomedical Research Workforce: Supporting More Investigators Sustainability and Efficiently |
| 4:00 p.m. | Concept Clearances NIDA Staff |
| 4:30 p.m. | Public Comments |
| 4:45 p.m. | Adjourn |